Literature DB >> 15662706

Investigations into the etiology of neural tube defects.

Robert M Cabrera1, Denise S Hill, Analee J Etheredge, Richard H Finnell.   

Abstract

Neural tube defects (NTDs) are serious malformations affecting approximately 1 per 1000 births, yet the mechanisms by which they arise are unknown. There have been consistent efforts in many fields of research to elucidate the etiology of this multifactorial condition. While no single gene has been identified as a major independent risk factor for NTDs, candidate genes have been proposed that may modify the effects of maternal and/or embryonic exposures. Folate supplementation effectively reduces the occurrence of NTDs and, consequently, has focused much research on metabolism of folate-related pathways during pregnancy and development. Further understanding of normal development and how teratogens can perturb these orchestrated processes also remains at the fore of modern scientific endeavors. The composite of these factors remains fragmented; the aim of this review is to provide the reader with a summary of sentinel and current works in the body of literature addressing NTD disease etiology. 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15662706     DOI: 10.1002/bdrc.20025

Source DB:  PubMed          Journal:  Birth Defects Res C Embryo Today        ISSN: 1542-975X


  18 in total

Review 1.  Experimental models of spinal open neural tube defect and Chiari type II malformation.

Authors:  Ki-Bum Sim; Ji Yeoun Lee; Ji Hoon Phi; Seung-Ki Kim; Kyu-Chang Wang
Journal:  Childs Nerv Syst       Date:  2013-09-07       Impact factor: 1.475

2.  Autoantibodies to folate receptor during pregnancy and neural tube defect risk.

Authors:  Robert M Cabrera; Gary M Shaw; Johnathan L Ballard; Suzan L Carmichael; Wei Yang; Edward J Lammer; Richard H Finnell
Journal:  J Reprod Immunol       Date:  2008-09-18       Impact factor: 4.054

3.  Mutations in folate transporter genes and risk for human myelomeningocele.

Authors:  Tina O Findley; Joy C Tenpenny; Michelle R O'Byrne; Alanna C Morrison; James E Hixson; Hope Northrup; Kit Sing Au
Journal:  Am J Med Genet A       Date:  2017-09-26       Impact factor: 2.802

4.  Maternal-fetal metabolic gene-gene interactions and risk of neural tube defects.

Authors:  Philip J Lupo; Laura E Mitchell; Mark A Canfield; Gary M Shaw; Andrew F Olshan; Richard H Finnell; Huiping Zhu
Journal:  Mol Genet Metab       Date:  2013-11-18       Impact factor: 4.797

5.  Association of folate receptor (FOLR1, FOLR2, FOLR3) and reduced folate carrier (SLC19A1) genes with meningomyelocele.

Authors:  Michelle R O'Byrne; Kit Sing Au; Alanna C Morrison; Jone-Ing Lin; Jack M Fletcher; Kathryn K Ostermaier; Gayle H Tyerman; Sabine Doebel; Hope Northrup
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-08

6.  Neural tube defects in mice exposed to tap water.

Authors:  Murali K Mallela; Stephen R Werre; Terry C Hrubec
Journal:  Environ Toxicol       Date:  2010-06-01       Impact factor: 4.119

7.  Valproic acid antagonizes the capacity of other histone deacetylase inhibitors to activate the Epstein-barr virus lytic cycle.

Authors:  Derek Daigle; Lyn Gradoville; David Tuck; Vince Schulz; Ruth Wang'ondu; Jianjiang Ye; Kelly Gorres; George Miller
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

Review 8.  Neural tube defects and folate: case far from closed.

Authors:  Henk J Blom; Gary M Shaw; Martin den Heijer; Richard H Finnell
Journal:  Nat Rev Neurosci       Date:  2006-09       Impact factor: 34.870

9.  Prevalence of neural tube defects in economically and socially deprived area of China.

Authors:  Jie Liu; Guo Z Yang; Jin L Zhou; Shi P Cao; David H W Chau; Hsiang-Fu Kung; Marie C Lin
Journal:  Childs Nerv Syst       Date:  2007-04-21       Impact factor: 1.475

10.  Fumonisins: current research trends in developmental toxicology.

Authors:  K A Voss; J B Gelineau-van Waes; R T Riley
Journal:  Mycotoxin Res       Date:  2006-03       Impact factor: 3.833

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.